Amyotrophic Lateral Sclerosis (ALS) Infographics

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is a group of rare neurological diseases that mainly involve the nerve cells (neurons), responsible for controlling voluntary muscle movement. Voluntary muscles produce movements like chewing, walking, and talking. The disease is progressive, meaning the symptoms get worse over time. ALS belongs to a broader group of disorders known as motor neuron diseases, which are caused by gradual deterioration and death of motor neurons.

Amyotrophic Lateral Sclerosis Epidemiology Segmentation in the 7MM

• Prevalent Population of Amyotrophic Lateral Sclerosis
• Diagnosed Prevalent Population of Amyotrophic Lateral Sclerosis
• Gender-Specific Population of Amyotrophic Lateral Sclerosis
• Mutation-Specific Population of Amyotrophic Lateral Sclerosis
• Type-specific Population of Amyotrophic Lateral Sclerosis
• Amyotrophic Lateral Sclerosis cases based on Site of Onset
• Age-specific Population of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis Epidemiological Insights Observed in the 7MM in 2023

• The total diagnosed prevalent cases of Amyotrophic Lateral Sclerosis in the 7MM were found to be 67k in the year 2021.
• 90% of cases are sporadic in the US.

Amyotrophic Lateral Sclerosis Market Insight

The market size of Amyotrophic Lateral Sclerosis in the 7MM was found to be approximately USD 1 billion in 2023.

Amyotrophic Lateral Sclerosis Market Drivers

• Availability of Epidemiological Data
• Robust Pipeline Activity
• Increasing Awareness Programs

Amyotrophic Lateral Sclerosis Market Barriers

• High Medical Cost
• Lack of Proper Diagnosis
• High Mortality Rate
• No cure, only delaying progression

Amyotrophic Lateral Sclerosis Emerging Therapies

The emerging drugsin the Amyotrophic Lateral Sclerosis market are

• Tofersen (BIIB067)
• ION363
• Ibudilast
• Masitinib
• AMX0035
• EPI-589
• Verdiperstat
• Zilucoplan
• AT-1501
• RNS60, and many others

Amyotrophic Lateral Sclerosis Key Players

The key players working in the Amyotrophic Lateral Sclerosis market are

• Ionis Pharmaceuticals
• MediciNova
• Amylyx Pharmaceuticals
• Seelos Therapeutics
• Prilenia Therapeutics
• Biohaven Pharmaceuticals
• Apellis Pharmaceuticals
• Eledon Pharmaceuticals
• NeuroSense Therapeutics
• Biogen, and many more